A 34-gene expression biomarker predicts meningioma outcomes and radiotherapy responses

Neuro Oncol. 2024 Feb 2;26(2):207-208. doi: 10.1093/neuonc/noad212.

Authors

David R Raleigh¹, Matthias Preusser²

Affiliations

¹ Departments of Radiation Oncology, Neurological Surgery, and Pathology, University of California San Francisco, San Francisco, California, USA.
² Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria (M.P.).

PMID: 37963810
PMCID: PMC10836762 (available on 2024-11-15)
DOI: 10.1093/neuonc/noad212

No abstract available

MeSH terms

Biomarkers
Gene Expression
Humans
Meningeal Neoplasms* / genetics
Meningeal Neoplasms* / radiotherapy
Meningioma* / genetics
Meningioma* / radiotherapy
Radiotherapy
Radiotherapy, Adjuvant
Retrospective Studies
Treatment Outcome

Substances

Biomarkers